Berdini; Valerio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Berdini; Valerio.The latest application filed is for "pyrazolyl quinoxaline kinase inhibitors".

Company Profile

7.58.61

Berdini; Valerio - Cambridge GB
Berdini; Valerio - Milan IT
BERDINI; Valerio - L'Aquila IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazolyl Quinoxaline Kinase Inhibitors App 20220135544 - SAXTY; Gordon ; et al.	2022-05-05
Benzolactam compounds as protein kinase inhibitors Grant 11,001,575 - Berdini , et al. May 11, 2	2021-05-11
Pyrazolyl Quinoxaline Kinase Inhibitors App 20200131153 - SAXTY; Gordon ; et al.	2020-04-30
Pyrazolyl quinoxaline kinase inhibitors Grant 10,519,137 - Saxty , et al. Dec	2019-12-31
Benzolactam compounds as protein kinase inhibitors Grant 10,457,669 - Berdini , et al. Oc	2019-10-29
Pteridines as FGFR inhibitors Grant 10,272,087 - Saxty , et al.	2019-04-30
Benzolactam Compounds As Protein Kinase Inhibitors App 20190047990 - BERDINI; Valerio ; et al.	2019-02-14
Substituted quinoxalines as FGFR kinase inhibitors Grant 10,052,320 - Woodhead , et al. August 21, 2	2018-08-21
Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors Grant 10,045,982 - Berdini , et al. August 14, 2	2018-08-14
Quinolines as FGFR kinase modulators Grant 10,039,759 - Berdini , et al. August 7, 2	2018-08-07
Pyrazolyl Quinoxaline Kinase Inhibitors App 20180127397 - SAXTY; Gordon ; et al.	2018-05-10
Substituted quinoxalines as FGFR kinase inhibitors Grant 9,856,236 - Saxty , et al. January 2, 2	2018-01-02
Pyrazolyl quinoxaline kinase inhibitors Grant 9,850,228 - Saxty , et al. December 26, 2	2017-12-26
Pteridines As Fgfr Inhibitors App 20170000796 - SAXTY; Gordon ; et al.	2017-01-05
Quinolines As Fgfr Kinase Modulators App 20170000781 - BERDINI; Valerio ; et al.	2017-01-05
Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells Grant 9,493,402 - Allegretti , et al. November 15, 2	2016-11-15
Pyrazolyl Quinoxaline Kinase Inhibitors App 20160311800 - SAXTY; Gordon ; et al.	2016-10-27
Pyrazolyl quinoxaline kinase inhibitors Grant 9,464,071 - Saxty , et al. October 11, 2	2016-10-11
Pteridines as FGFR inhibitors Grant 9,447,098 - Saxty , et al. September 20, 2	2016-09-20
Quinolines as FGFR kinase modulators Grant 9,439,896 - Berdini , et al. September 13, 2	2016-09-13
Pyrazole Derivatives As Protein Kinase Modulators App 20160250187 - BERDINI; Valerio ; et al.	2016-09-01
SUBSTITUTED PYRIDO[2,3-b]PYRAZINES AS FGFR KINASE INHIBITORS App 20160235744 - BERDINI; Valerio ; et al.	2016-08-18
Substitutued Quinoxalines As Fgfr Kinase Inhibitors App 20160220564 - WOODHEAD; Steven John ; et al.	2016-08-04
Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors Grant 9,309,242 - Berdini , et al. April 12, 2	2016-04-12
Substituted quinoxalines as FGFR kinase inhibitors Grant 9,303,029 - Woodhead , et al. April 5, 2	2016-04-05
Substituted quinoxalines as FGFR kinase inhibitors Grant 9,290,478 - Saxty , et al. March 22, 2	2016-03-22
Pyrazole derivatives as protein kinase modulators Grant 9,283,226 - Berdini , et al. March 15, 2	2016-03-15
Substituted Quinoxalines As Fgfr Kinase Inhibitors App 20160031856 - SAXTY; Gordon ; et al.	2016-02-04
Pteridines As Fgfr Inhibitors App 20150291589 - Saxty; Gordon ; et al.	2015-10-15
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators Grant 9,051,278 - Berdini , et al. June 9, 2	2015-06-09
Pyrazolyl Quinoxaline Kinase Inhibitors App 20150105368 - SAXTY; Gordon ; et al.	2015-04-16
Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein Grant 9,006,430 - Berdini , et al. April 14, 2	2015-04-14
Anticancer Benzopyrazines Via The Inhibition Of Fgfr Kinases App 20150031669 - Woodhead; Steven John ; et al.	2015-01-29
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators App 20140371213 - BERDINI; Valerio ; et al.	2014-12-18
Bicyclic heterocyclic compounds as FGFR inhibitors Grant 8,895,745 - Berdini , et al. November 25, 2	2014-11-25
Pyrazolyl quinoxaline kinase inhibitors Grant 8,895,601 - Saxty , et al. November 25, 2	2014-11-25
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,859,582 - Saxty , et al. October 14, 2	2014-10-14
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,859,583 - Saxty , et al. October 14, 2	2014-10-14
Ortho-condensed Pyridine And Pyrimidine Derivatives (e.g., Purines) As Protein Kinases Inhibitors App 20140303177 - BERDINI; Valerio ; et al.	2014-10-09
Quinolines As Fgfr Kinase Modulators App 20140296236 - Berdini; Valerio ; et al.	2014-10-02
Anticancer Pyridopyrazines Via The Inhibition Of Fgfr Kinases App 20140288053 - Berdini; Valerio ; et al.	2014-09-25
Pyrazole Derivatives As Protein Kinase Modulators App 20140271662 - BERDINI; Valerio ; et al.	2014-09-18
Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors Grant 8,809,336 - Berdini , et al. August 19, 2	2014-08-19
Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases Grant 8,796,244 - Berdini , et al. August 5, 2	2014-08-05
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators Grant 8,779,147 - Berdini , et al. July 15, 2	2014-07-15
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases Grant 8,778,936 - Berdini , et al. July 15, 2	2014-07-15
Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy Grant 8,722,687 - Saxty , et al. May 13, 2	2014-05-13
Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors App 20140107137 - BERDINI; Valerio ; et al.	2014-04-17
Pyrazole derivatives as protein kinase modulators Grant 8,691,806 - Berdini , et al. April 8, 2	2014-04-08
Benzimidazole Derivatives And Their Use As Protein Kinase Inhibitors App 20140010892 - BERDINI; Valerio ; et al.	2014-01-09
Substituted Benzopyrazin Derivatives As Fgfr Kinase Inhibitors For The Treatment Of Cancer Diseases App 20130267525 - Saxty; Gordon ; et al.	2013-10-10
Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors Grant 8,546,407 - Berdini , et al. October 1, 2	2013-10-01
Imidazo[1,2-a]pyridine compounds for use in treating cancer Grant 8,513,276 - Berdini , et al. August 20, 2	2013-08-20
Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use Grant 8,481,531 - Saxty , et al. July 9, 2	2013-07-09
"omega-aminoalkylamides Of R-2-aryl-propionic Acids Asinhibitors Of The Chemotaxis Of Polymorphonucleate Andmononucleate Cells" App 20130079514 - ALLEGRETTI; Marcello ; et al.	2013-03-28
Pyrazolyl Quinazoline Kinase Inhibitors App 20130072457 - Saxty; Gordon ; et al.	2013-03-21
Pharmaceutical compounds Grant 8,399,442 - Berdini , et al. March 19, 2	2013-03-19
Pyrazole Derivatives As Protein Kinase Modulators App 20130005702 - BERDINI; Valerio ; et al.	2013-01-03
Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells Grant 8,288,368 - Allegretti , et al. October 16, 2	2012-10-16
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators App 20120213791 - BERDINI; Valerio ; et al.	2012-08-23
Pyrazole derivatives as protein kinase modulators Grant 8,247,576 - Berdini , et al. August 21, 2	2012-08-21
Imidazopyridine Derivatives As Inhibitors Of Receptor Tyrosine Kinases App 20120208791 - Berdini; Valerio ; et al.	2012-08-16
Pyrazole Compounds That Modulate The Activity Of Cdk, Gsk And Aurora Kinases App 20120190673 - BERDINI; Valerio ; et al.	2012-07-26
FGFR pharmacophore compounds Grant 8,131,527 - Saxty , et al. March 6, 2	2012-03-06
Imidazo [1,2-a]pyridine Derivatives As Fgfr Kinase Inhibitors For Use In Therapy App 20120041000 - Saxty; Gordon ; et al.	2012-02-16
Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20120035153 - SAXTY; Gordon ; et al.	2012-02-09
Bicyclic Heterocyclyl Derivatives As Fgfr Kinase Inhibitors For Therapeutic Use App 20120035171 - Saxty; Gordon ; et al.	2012-02-09
Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20120035152 - SAXTY; Gordon ; et al.	2012-02-09
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases Grant 8,110,573 - Berdini , et al. February 7, 2	2012-02-07
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators Grant 8,080,666 - Berdini , et al. December 20, 2	2011-12-20
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,076,354 - Saxty , et al. December 13, 2	2011-12-13
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,071,614 - Saxty , et al. December 6, 2	2011-12-06
Benzimidazole Derivatives And Their Use As Protein Kinase Inhibitors App 20110224203 - BERDINI; Valerio ; et al.	2011-09-15
Benzimidazole derivatives and their use as protein kinase inhibitors Grant 7,977,477 - Berdini , et al. July 12, 2	2011-07-12
Pyrazole Derivatives As Protein Kinase Modulators App 20110144080 - Berdini; Valerio ; et al.	2011-06-16
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators App 20110003799 - BERDINI; Valerio ; et al.	2011-01-06
Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20100331296 - Saxty; Gordon ; et al.	2010-12-30
Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20100286113 - Saxty; Gordon ; et al.	2010-11-11
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators Grant 7,825,140 - Berdini , et al. November 2, 2	2010-11-02
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators Grant 7,745,638 - Berdini , et al. June 29, 2	2010-06-29
Pyrazole Derivatives As That Modulate The Activity Of Cdk, Gsk And Aurora Kinases App 20100160324 - Berdini; Valerio ; et al.	2010-06-24
Bicyclic Heterocyclic Compounds as FGFR Inhibitors App 20100120761 - Berdini; Valerio ; et al.	2010-05-13
Compounds App 20100093718 - Berdini; Valerio ; et al.	2010-04-15
Pharmaceutical Compounds App 20100004232 - Berdini; Valerio ; et al.	2010-01-07
Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors App 20090247538 - Berdini; Valerio ; et al.	2009-10-01
Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors App 20090099213 - Berdini; Valerio ; et al.	2009-04-16
Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora Kinases App 20080312223 - Berdini; Valerio ; et al.	2008-12-18
Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S App 20080306069 - Wyatt; Paul Graham ; et al.	2008-12-11
Compounds for Treating Protein-Kinase Mediated Disorders App 20080275029 - Berdini; Valerio ; et al.	2008-11-06
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators App 20080269207 - Berdini; Valerio ; et al.	2008-10-30
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators App 20080200509 - Berdini; Valerio ; et al.	2008-08-21
Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's App 20080194562 - Wyatt; Paul Graham ; et al.	2008-08-14
Pharmaceutical Compounds App 20080167309 - Berdini; Valerio ; et al.	2008-07-10
Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's App 20080139620 - Wyatt; Paul Graham ; et al.	2008-06-12
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators Grant 7,385,059 - Berdini , et al. June 10, 2	2008-06-10
Pyrazole Compounds that Modulate the Activity of Cdk, Gsk and Aurora Kinases App 20080132495 - Berdini; Valerio ; et al.	2008-06-05
Omega-aminoalkylamides Of R-2-aryl-propionic Acids As Inhibitors Of The Chemotaxis Of Polymorphonucleate And Mononucleate Cells App 20080045522 - ALLEGRETTI; Marcello ; et al.	2008-02-21
3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors App 20080004270 - Gill; Adrian Liam ; et al.	2008-01-03
Benzimidazole derivatives and their use as protein kinases inhibitors App 20070135477 - Berdini; Valerio ; et al.	2007-06-14
Pharmaceutical compounds App 20070105900 - Berdini; Valerio ; et al.	2007-05-10
3,4-Disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators App 20060194843 - Berdini; Valerio ; et al.	2006-08-31
3-(Carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors App 20060135516 - Berdini; Valerio ; et al.	2006-06-22
Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells App 20050080067 - Allegretti, Marcello ; et al.	2005-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.